Display options
Cite
Demir IE, Reyes CM, Alrawashdeh W, et al. Future directions in preclinical and translational cancer neuroscience research. Nat Cancer. 2020;1:1027-1031doi: 10.1038/s43018-020-00146-9.
Demir, I. E., Reyes, C. M., Alrawashdeh, W., Ceyhan, G. O., Deborde, S., Friess, H., Görgülü, K., Istvanffy, R., Jungwirth, D., Kuner, R., Maryanovich, M., Na'ara, S., Renders, S., Saloman, J. L., Scheff, N. N., Steenfadt, H., Stupakov, P., Thiel, V., Verma, D., Yilmaz, B. S., White, R. A., Wang, T. C., Wong, R. J., Frenette, P. S., Gil, Z., & Davis, B. M. (2021). Future directions in preclinical and translational cancer neuroscience research. Nature cancer, 11027-1031. https://doi.org/10.1038/s43018-020-00146-9
Demir, Ihsan Ekin, et al. "Future directions in preclinical and translational cancer neuroscience research." Nature cancer vol. 1 (2021): 1027-1031. doi: https://doi.org/10.1038/s43018-020-00146-9
Demir IE, Reyes CM, Alrawashdeh W, Ceyhan GO, Deborde S, Friess H, Görgülü K, Istvanffy R, Jungwirth D, Kuner R, Maryanovich M, Na'ara S, Renders S, Saloman JL, Scheff NN, Steenfadt H, Stupakov P, Thiel V, Verma D, Yilmaz BS, White RA, Wang TC, Wong RJ, Frenette PS, Gil Z, Davis BM. Future directions in preclinical and translational cancer neuroscience research. Nat Cancer. 2021 Nov;1:1027-1031. doi: 10.1038/s43018-020-00146-9. Epub 2020 Nov 17. PMID: 34327335; PMCID: PMC8315010.
Copy Download .nbib Format: NLM
Share it on

Nat Cancer. 2021 Nov;1:1027-1031. doi: 10.1038/s43018-020-00146-9. Epub 2020 Nov 17.

Future directions in preclinical and translational cancer neuroscience research.

Nature cancer

Ihsan Ekin Demir, Carmen Mota Reyes, Wasfi Alrawashdeh, Güralp O Ceyhan, Sylvie Deborde, Helmut Friess, Kıvanç Görgülü, Rouzanna Istvanffy, David Jungwirth, Rohini Kuner, Maria Maryanovich, Shorook Na'ara, Simon Renders, Jami L Saloman, Nicole N Scheff, Hendrik Steenfadt, Pavel Stupakov, Vera Thiel, Divij Verma, Bengi Su Yilmaz, Ruth A White, Timothy C Wang, Richard J Wong, Paul S Frenette, Ziv Gil, Brian M Davis

Affiliations

  1. Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
  2. Department of General Surgery, HPB-Unit, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
  3. German Cancer Consortium (DKTK), Partner Site Munich, Germany.
  4. CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
  5. Department of HPB and Transplant Surgery, The Freeman Hospital, Newcastle upon Tyne, Tyne and Wear, United Kingdom.
  6. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  7. Comprehensive Cancer Center Munich, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
  8. Department of Molecular Pharmacology, Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
  9. Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  10. Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  11. Department of Otolaryngology, Head and Neck Surgery, and the Laboratory for Applied Cancer Research, Rappaport Institute of Medicine and Research, The Technion, Israel Institute of Technology, Haifa, Israel.
  12. Head and Neck Center, Rambam Healthcare Campus, Haifa, Israel.
  13. Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany.
  14. Department of Medicine, Division of Gastroenterology, Hepatology, & Nutrition, Center for Neuroscience at the University of Pittsburgh, Pittsburgh Center for Pain Research and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  15. Hillman Cancer Center and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  16. Division of Hematology ad Oncology, Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY, USA.
  17. Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY, USA.
  18. Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  19. Center for Neuroscience at the University of Pittsburgh, Pittsburgh Center for Pain Research and, Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

PMID: 34327335 PMCID: PMC8315010 DOI: 10.1038/s43018-020-00146-9

Abstract

Recent advances in cancer neuroscience necessitate the systematic analysis of neural influences in cancer as potential therapeutic targets in oncology. Here, we outline recommendations for future preclinical and translational research in this field.

References

  1. Nat Biotechnol. 2020 May;38(5):629-637 - PubMed
  2. Nature. 2014 Aug 7;512(7512):78-81 - PubMed
  3. Curr Opin Neurobiol. 2020 Jun;62:60-67 - PubMed
  4. J Clin Invest. 2016 Apr 1;126(4):1538-54 - PubMed
  5. Nat Rev Neurosci. 2006 Oct;7(10):797-809 - PubMed
  6. Gastroenterology. 2019 Aug;157(2):522-536.e2 - PubMed
  7. Nat Rev Gastroenterol Hepatol. 2015 Nov;12(11):649-59 - PubMed
  8. Nat Rev Cancer. 2016 Jun;16(6):399-408 - PubMed
  9. Nat Neurosci. 2019 Aug;22(8):1289-1305 - PubMed
  10. Stem Cells Int. 2016;2016:3710836 - PubMed
  11. J Neurosci Res. 2017 Jun;95(6):1242-1256 - PubMed
  12. Expert Opin Ther Pat. 2017 Jul;27(7):831-849 - PubMed
  13. Nat Rev Cancer. 2020 Mar;20(3):143-157 - PubMed
  14. Gastroenterology. 2009 Jan;136(1):177-186.e1 - PubMed
  15. J Vis Exp. 2020 May 7;(159): - PubMed

Publication Types

Grant support